(2021) 31:R496552
The safety profile was indistinguishable from placebo
PubMed Zhang, C., Chopp, M., Cui, Y., Wang, L., Zhang, R., Zhang, L., Lu, M., Szalad, A., Doppler, E., Hitzl, M., & Zhang, Z.G
Interestingly, by combining GLP-1 and GIP agonism into a single molecule, the GIP/GLP-1 coagonist has enhanced therapeutic properties to improve glucose tolerance and induce weight loss, which was demonstrated in rodents, non-human primates and humans (Finan et al., 2013)
Used together, they address the full spectrum of skin aging, giving you a complexion that looks both firm and luminous
BPC 157 / TB-500 60 Capsule (500mcg / 500mcg) $100.00 BPC-157 and TB-500 research blend (500mcg/500mcg) combines two of the most studied synthetic peptides in preclinical connective tissue research